NCT00524537View on ClinicalTrials.gov

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

CompletedOBSERVATIONAL
Enrollment

5,025

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Crohn's Disease
All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT00524537 - A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD) | Biotech Hunter | Biotech Hunter